These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36637582)

  • 1. The non-invasive diagnosis of colorectal cancer via a SOX9-based gene panel.
    Xue VW; Ng SSM; Tsang HF; Wong HT; Leung WW; Wong YN; Wong YKE; Yu ACS; Yim AKY; Cho WCS; Tai WCS; Wong SCC
    Clin Exp Med; 2023 Oct; 23(6):2421-2432. PubMed ID: 36637582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic profiling and mRNA expression reveal candidate genes as biomarkers for colorectal cancer.
    Zhang H; Dong S; Feng J
    J Cell Biochem; 2019 Jun; 120(6):10767-10776. PubMed ID: 30672027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SOX9-activated FARSA-AS1 predetermines cell growth, stemness, and metastasis in colorectal cancer through upregulating FARSA and SOX9.
    Zhou T; Wu L; Ma N; Tang F; Yu Z; Jiang Z; Li Y; Zong Z; Hu K
    Cell Death Dis; 2020 Dec; 11(12):1071. PubMed ID: 33318478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroxisome proliferator-activated receptor γ-mediated induction of microRNA-145 opposes tumor phenotype in colorectal cancer.
    Panza A; Votino C; Gentile A; Valvano MR; Colangelo T; Pancione M; Micale L; Merla G; Andriulli A; Sabatino L; Vinciguerra M; Prattichizzo C; Mazzoccoli G; Colantuoni V; Piepoli A
    Biochim Biophys Acta; 2014 Jun; 1843(6):1225-36. PubMed ID: 24631504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SOX9, miR-495, miR-590-3p, and miR-320d were identified as chemoradiotherapy-sensitive genes and miRNAs in colorectal cancer patients based on a microarray dataset.
    Du B; Wang T; Yang X; Wang J; Shi X; Wang X; Wu D; Feng L; Chen L; Zhang W
    Neoplasma; 2019 Jan; 66(1):8-19. PubMed ID: 30509082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Enhancer-Driven Stem Cell-Like Program Mediated by SOX9 Blocks Intestinal Differentiation in Colorectal Cancer.
    Liang X; Duronio GN; Yang Y; Bala P; Hebbar P; Spisak S; Sahgal P; Singh H; Zhang Y; Xie Y; Cejas P; Long HW; Bass AJ; Sethi NS
    Gastroenterology; 2022 Jan; 162(1):209-222. PubMed ID: 34571027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interplay between SOX9, β-catenin and PPARγ activation in colorectal cancer.
    Panza A; Pazienza V; Ripoli M; Benegiamo G; Gentile A; Valvano MR; Augello B; Merla G; Prattichizzo C; Tavano F; Ranieri E; di Sebastiano P; Vinciguerra M; Andriulli A; Mazzoccoli G; Piepoli A
    Biochim Biophys Acta; 2013 Aug; 1833(8):1853-65. PubMed ID: 23583560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ZRANB1 enhances stem-cell-like features and accelerates tumor progression by regulating Sox9-mediated USP22/Wnt/β-catenin pathway in colorectal cancer.
    Miao D; Wang Y; Jia Y; Tong J; Jiang S; Liu L
    Cell Signal; 2022 Feb; 90():110200. PubMed ID: 34798260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LINC00839 promotes colorectal cancer progression by recruiting RUVBL1/Tip60 complexes to activate NRF1.
    Liu X; Chen J; Zhang S; Liu X; Long X; Lan J; Zhou M; Zheng L; Zhou J
    EMBO Rep; 2022 Sep; 23(9):e54128. PubMed ID: 35876654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SOX9 is an atypical intestinal tumor suppressor controlling the oncogenic Wnt/ß-catenin signaling.
    Prévostel C; Rammah-Bouazza C; Trauchessec H; Canterel-Thouennon L; Busson M; Ychou M; Blache P
    Oncotarget; 2016 Dec; 7(50):82228-82243. PubMed ID: 27429045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EIF3D promotes resistance to 5-fluorouracil in colorectal cancer through upregulating RUVBL1.
    Li C; Lu K; Yang C; Du W; Liang Z
    J Clin Lab Anal; 2023 Jan; 37(2):e24825. PubMed ID: 36592991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-invasive Potential Circulating mRNA Markers for Colorectal Adenoma Using Targeted Sequencing.
    Xue VW; Cheung MT; Chan PT; Luk LLY; Lee VH; Au TC; Yu AC; Cho WCS; Tsang HFA; Chan AK; Wong SCC
    Sci Rep; 2019 Sep; 9(1):12943. PubMed ID: 31506480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CircMYO10 promotes osteosarcoma progression by regulating miR-370-3p/RUVBL1 axis to enhance the transcriptional activity of β-catenin/LEF1 complex via effects on chromatin remodeling.
    Chen J; Liu G; Wu Y; Ma J; Wu H; Xie Z; Chen S; Yang Y; Wang S; Shen P; Fang Y; Fan S; Shen S; Fang X
    Mol Cancer; 2019 Oct; 18(1):150. PubMed ID: 31665067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Four-Gene Panel in Rectal Swab Samples as a Biomarker for Colorectal Cancer Screening.
    Ng L; Wong SK; Li HS; Sin RW; Man JH; Lo OS; Pang RW; Foo DC; Law WL
    Cells; 2024 May; 13(11):. PubMed ID: 38891062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of serum Metadherin mRNA expression in the diagnosis and prediction of survival in patients with colorectal cancer.
    Abdel Ghafar MT; Gharib F; Abdel-Salam S; Elkhouly RA; Elshora A; Shalaby KH; El-Guindy D; El-Rashidy MA; Soliman NA; Abu-Elenin MM; Allam AA
    Mol Biol Rep; 2020 Apr; 47(4):2509-2519. PubMed ID: 32088817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sox9 mediated transcriptional activation of FOXK2 is critical for colorectal cancer cells proliferation.
    Qian Y; Xia S; Feng Z
    Biochem Biophys Res Commun; 2017 Jan; 483(1):475-481. PubMed ID: 28007600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA LINC00963 promotes proliferation and migration through the miR-124-3p/FZD4 pathway in colorectal cancer.
    Zheng K; Zhang TK
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7634-7644. PubMed ID: 32744689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrent, truncating SOX9 mutations are associated with SOX9 overexpression, KRAS mutation, and TP53 wild type status in colorectal carcinoma.
    Javier BM; Yaeger R; Wang L; Sanchez-Vega F; Zehir A; Middha S; Sadowska J; Vakiani E; Shia J; Klimstra D; Ladanyi M; Iacobuzio-Donahue CA; Hechtman JF
    Oncotarget; 2016 Aug; 7(32):50875-50882. PubMed ID: 27248473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma Circulating mRNA Profile for the Non-Invasive Diagnosis of Colorectal Cancer Using NanoString Technologies.
    Tsang HF; Pei XM; Wong YKE; Wong SCC
    Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible involvement of Wnt11 in colorectal cancer progression.
    Nishioka M; Ueno K; Hazama S; Okada T; Sakai K; Suehiro Y; Okayama N; Hirata H; Oka M; Imai K; Dahiya R; Hinoda Y
    Mol Carcinog; 2013 Mar; 52(3):207-17. PubMed ID: 22161723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.